Ahlering Peter, Sutovsky Miriam, Gliedt Douglas, Branson Kellie, Miranda Vizuete Antonio, Sutovsky Peter
Missouri Center for Reproductive Medicine , Chesterfield, MO, USA.
Division of Animal Sciences, University of Missouri , Columbia, MO, 65211-5300, USA.
Syst Biol Reprod Med. 2020 Oct;66(5):311-321. doi: 10.1080/19396368.2020.1801889. Epub 2020 Aug 27.
Male germline-specific thioredoxin domain containing 8 (TXNDC8; alias SPTRX3) accumulates indefective human spermatozoa. We assessed the efficiency of two-step semen purification inremoving spermatozoa carrying TXNDC8, and examined the relationship of TXNDC8 with theoutcomes of assisted reproductive therapy (ART), conventional semen parameters, and sperm DNA integrity in sperm chromatin structure assay (SCSA). Semen samples (n = 255) from 91 ART couples were screened in two independent trials, both including a two-step, gradient-and-swim-up separation procedure yielding A-samples (raw semen), B-samples (gradient separated), and C-samples (gradient-and-swim-up). The C-samples were used for intracytoplasmic sperm injection (ICSI) with morphologically selected spermatozoa (IMSSI). Percentage of TXNDC8-positive spermatozoaincreased progressively from A to B/C-samples in both trials. In the first trial (35 couples), the TXNDC8 correlated positively with sperm DNA fragmentation index (%DFI; r = 0.66) measured before separation, and negatively with sperm concentration (r = -0.57) and motility (r = -0.67), also taken before separation. The high DNA stainability index (%HDS) correlated with the percentage of spermatozoa lacking TXNDC8 (r = 0.68). Both SCSA and TXNDC8 parameters showed moderate correlations (r = 0.33-0.66) with blood serum levels of hCG on day 11 (Beta 1) and day13 (Beta 2) after oocyte retrieval. In the second trial (56 couples), fathers of multiplets had a significantly lower percentage of TXNDC8-positive spermatozoa in B-sample (gradient separationonly) compared to men who conceived a singleton pregnancy (p = 0.01) and those who produced no pregnancy (p = 0.02). Those multiplets' fathers also had a significantly higher sperm concentration while their SCSA parameters did not differ from others. It is concluded that theTXNDC8 levels correlate with SCSA and conventional raw semen parameters, and are predictive of pregnancy outcome and multiple births after ART. Two-step purification does not efficiently remove TXNDC8 carrying spermatozoa.
ART- assisted reproductive therapy; DFI- DNA fragmentation index; FC- flow cytometry (FC); hCG: human chorionic gonadotropin; HDS: high DNA stainability index; HEPES- (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid); HTF- human tubal fluid; ICSI- intracytoplasmic sperm injection; IgG- immunoglobulin G; IMSSI- ICSI with morphologically selected spermatozoa; IVF- fertilization; IU-: intrauterine insemination; NGS- normal goat serum; PBS- phosphate buffered saline; PVP- polyvinylpyrrolidone; SAB- spontaneous abortion; SCSA- sperm chromatin structure assay; SPTRX3- spermatid specific thioredoxin 3; SSS- synthetic serum substitute; TRITC- tetramethyl rhodamine isothiocyanate; TX-100- Triton X-100; TXNDC- thioredoxin domain-containing proteins; TXNDC8- thioredoxin domain containing 8; TUNEL- Terminal deoxynucleotidyl transferase dUTP nick end labeling.
含8的雄性生殖系特异性硫氧还蛋白结构域(TXNDC8;别名SPTRX3)在有缺陷的人类精子中积累。我们评估了两步精液纯化法去除携带TXNDC8精子的效率,并在精子染色质结构分析(SCSA)中研究了TXNDC8与辅助生殖治疗(ART)结果、传统精液参数及精子DNA完整性之间的关系。对91对接受ART治疗夫妇的精液样本(n = 255)进行了两项独立试验筛查,两项试验均包括两步梯度上浮分离程序,分别得到A样本(原始精液)、B样本(梯度分离样本)和C样本(梯度上浮样本)。C样本用于对形态学筛选精子进行卵胞浆内单精子注射(ICSI)(IMSSI)。在两项试验中,从A样本到B/C样本,携带TXNDC8的精子百分比均逐渐增加。在第一项试验(35对夫妇)中,TXNDC8与分离前测得的精子DNA碎片指数(%DFI;r = 0.66)呈正相关,与分离前的精子浓度(r = -0.57)和活力(r = -0.67)呈负相关。高DNA染色性指数(%HDS)与缺乏TXNDC8的精子百分比相关(r = 0.68)。SCSA和TXNDC8参数与取卵后第11天(β1)和第13天(β2)的血清人绒毛膜促性腺激素(hCG)水平均呈中度相关(r = 0.33 - 0.66)。在第二项试验(56对夫妇)中,与单胎妊娠男性(p = 0.01)和未妊娠男性(p = 0.02)相比,多胎妊娠父亲的B样本(仅梯度分离样本)中携带TXNDC8的精子百分比显著降低。这些多胎妊娠父亲的精子浓度也显著更高,而他们的SCSA参数与其他人无差异。结论是,TXNDC8水平与SCSA及传统原始精液参数相关,可预测ART后的妊娠结局和多胎分娩。两步纯化法不能有效去除携带TXNDC8的精子。
ART - 辅助生殖治疗;DFI - DNA碎片指数;FC - 流式细胞术(FC);hCG:人绒毛膜促性腺激素;HDS:高DNA染色性指数;HEPES - (4 - (2 - 羟乙基) - 1 - 哌嗪乙磺酸);HTF - 人类输卵管液;ICSI - 卵胞浆内单精子注射;IgG - 免疫球蛋白G;IMSSI - 对形态学筛选精子进行ICSI;IVF - 体外受精;IU - :宫内授精;NGS - 正常山羊血清;PBS - 磷酸盐缓冲盐水;PVP - 聚乙烯吡咯烷酮;SAB - 自然流产;SCSA - 精子染色质结构分析;SPTRX3 - 精子特异性硫氧还蛋白3;SSS - 合成血清替代品;TRITC - 四甲基罗丹明异硫氰酸酯;TX - 100 - 曲拉通X - 100;TXNDC - 含硫氧还蛋白结构域的蛋白质;TXNDC8 - 含8的硫氧还蛋白结构域;TUNEL - 末端脱氧核苷酸转移酶dUTP缺口末端标记